Nicholas Peckham
Medical Statistician
I am a medical statistician currently working on the design, conduct and analysis of clinical trials. I am part of the Oxford Clinical Trials Research Unit, and the Centre for Statistics in Medicine, where I provide statistical input and report writing for a variety of clinical trials. I am involved with a methodology research group looking at the statistical methods and reporting of trial publications. Other areas of interest include multivariate analysis of large data sets, machine learning, and experimental designs. I also teach the programming language Stata and occasionally help with the running of other statistical sessions.
I obtained an MSc in Statistics with Distinction from the University of Kent in 2018. I have an interest in the practical applications of statistics in reducing the burden of disease. For my dissertation, I assessed the suitability of using clustering algorithms to group countries together based on risk factors for non-communicable diseases. I have a BSc in Physics from the University of Leicester, where I graduated in 2015.
Outside of work, I enjoy playing football, rock climbing, chess and pub quizzes.
Key publications
-
Two-week interruption in methotrexate treatment versus treatment continued as usual and COVID-19 booster immunity in adults with inflammatory conditions (VROOM study): a randomised open label, superiority trial
Journal article
Abhishek A. et al, (2022), The lancet respiratory medicine
-
Current practice in analysing and reporting binary outcome data-a review of randomised controlled trial reports.
Journal article
Rombach I. et al, (2020), Bmc med, 18
-
Personalised high tibial osteotomy has mechanical safety equivalent to generic device in a case-control in silico clinical trial
Journal article
MacLeod A. et al, (2021), Communications medicine
-
The Underrepresentation of Females in Studies Assessing the Impact of High-Dose Exercise on Cardiovascular Outcomes: a Scoping Review
Journal article
Patel R. et al, (2021), Sports medicine
Recent publications
-
Progressive exercise versus best practice advice for adults aged 50 years or over after ankle fracture: the AFTER pilot randomised controlled trial.
Journal article
Keene DJ. et al, (2022), Bmj open, 12
-
Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot.
Journal article
Glyn-Jones S. et al, (2022), Health technol assess, 26, 1 - 58
-
A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.
Journal article
Speich B. et al, (2022), Trials, 23
-
Two-week interruption in methotrexate treatment versus treatment continued as usual and COVID-19 booster immunity in adults with inflammatory conditions (VROOM study): a randomised open label, superiority trial
Journal article
Abhishek A. et al, (2022), The lancet respiratory medicine
-
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
Journal article
Abhishek A. et al, (2022), Bmj open, 12